1
RO4929097 in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma That Can Be Removed by Surgery
Condition(s):Stage IIIB Melanoma; Stage IIIC Melanoma; Stage IV MelanomaLast Updated:January 31, 2013Withdrawn
Stage IIIB Melanoma: 163 Clinical Trials, Page 1 of 17
Hide Studies Not Open or Pending
2
Dinaciclib in Treating Patients With Stage III-IV Melanoma
Condition(s):Stage IIIB Melanoma; Stage IIIC Melanoma; Stage IV MelanomaLast Updated:April 4, 2017Terminated
3
A Study of Transgenic Lymphocyte Immunization (TLI) Against Telomerase in Subjects With Stage III Melanoma
Condition(s):Stage IIIB Skin Melanoma; Stage IIIC Skin MelanomaLast Updated:February 13, 2012Unknown status
4
Sorafenib and Isolated Limb Infusion of Melphalan in Treating Patients With Stage III Melanoma of the Arm or Leg
Condition(s):Melanoma (Skin)Last Updated:March 6, 2015Completed
5
Sorafenib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Stage III Melanoma
Condition(s):Melanoma (Skin)Last Updated:January 10, 2014Unknown status
6
Trametinib in Treating Patients With Advanced Melanoma With BRAF Non-V600 Mutations
Condition(s):Recurrent Melanoma; Stage IIIB Melanoma; Stage IIIC Melanoma; Stage IV MelanomaLast Updated:August 21, 2020Active, not recruiting
7
Vaccine Therapy in Treating Patients With Advanced Stage III-IV Melanoma
Condition(s):Recurrent Melanoma; Stage IIIB Skin Melanoma; Stage IIIC Skin Melanoma; Stage IV Skin MelanomaLast Updated:May 18, 2020Terminated
8
High-Dose Aldesleukin and Ipilimumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed By Surgery
Condition(s):Recurrent Melanoma; Stage IIIA Melanoma; Stage IIIB Melanoma; Stage IIIC Melanoma; Stage IV MelanomaLast Updated:June 19, 2020Completed
9
Selumetinib and Akt Inhibitor MK2206 in Treating Patients With Stage III or Stage IV Melanoma Who Failed Prior Therapy With Vemurafenib or Dabrafenib
Condition(s):Recurrent Melanoma; Stage IIIA Melanoma; Stage IIIB Melanoma; Stage IIIC Melanoma; Stage IV MelanomaLast Updated:June 18, 2014Terminated
10
Dasatinib in Treating Patients With Stage III Melanoma That Cannot Be Removed By Surgery or Stage IV Melanoma
Condition(s):Recurrent Melanoma; Stage IIIA Melanoma; Stage IIIB Melanoma; Stage IIIC Melanoma; Stage IV MelanomaLast Updated:May 15, 2014Completed